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Abstract 
Short communication on dic(9;17)(p13;q11) 
PAX5/TAOK1, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
Acute lymphoblastic leukemia (ALL) 
Epidemiology 
Only one case to date, a 3-year old girl with a pre-
B-ALL (Coyaud et al., 2010). 
Cytogenetics 
Additional anomalies 
There was a +X and additional rearrangements. 






391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry 
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments. Activates 
the surface cell receptor CD19 and repress FLT3. 
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and 
PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 





1001 amino acids (aa); from N-term to C-term, 
TAOK1 contains: a protein kinase domain (aa 28-
281), a nucleotide binding site (aa 34-42), a poly-
Glu stretch (aa 330-334), a Ser-rich region (aa 347-
379), and coiled coil domains (aa 458-651; 754-
877). Phosphorylation on Ser/Thr followed by Gln 
are the following: SQ motifs: aa 363-364; 554-555; 
990-991, TQ motifs: aa 502-503; 643-644; 785-786 
(Raman et al., 2007).  
TAOK1 is a serine/threonine-protein kinase. 
TAOK1 has the ability to phosphorylate MARK1 
(MAP/Microtubule affinity-regulating kinase 1, 
1q41), a kinase regulating microtubule dynamics 
and cell polarity (Timm et al., 2003). TAOK1 
regulates apoptotic morphology via C-Jun N-
terminal kinases (MAPK8, 10q11.22; MAPK9, 
5q35.3; MAPK10, 4q21.3) and ROCK1 (Rho-
associated, coiled-coil containing protein kinase 1, 
18q11.1) (Zihni et al., 2006).  
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PAX5-TAOK1 translocation protein. 
 
TAOK1 alters actin cytoskeletal organization and 
binds to microtubules, regulating their organization 
and stability (Zihni et al., 2006). The TAO kinases 
(TAOK1; TAOK2, 16p11.2; TAOK3, 12q24.23) 
mediate the activation of p38 (MAPK11, 22q13.33; 
MAPK12, 22q13.33; MAPK13, 6p21.31; 
MAPK14, 6p21.31) in response to various 
genotoxic stimuli.  
ATM (ataxia telangiectasia mutated, 11q22.3) 
phosphorylates the TAO kinases. TAO kinases are 
regulators of p38-mediated responses to DNA 
damage and are intermediates in the activation of 
p38 by ATM (Hutchison et al., 1998; Raman et al., 
2007).  
TESK1 (testis-specific kinase 1, 9p13.3) binds to 
and inhibits TAOK1. The elevation of TAOK1 
results in microtubule disruption. SPRED1 
(sprouty-related, EVH1 domain containing 1, 
15q14) - TESK1 binding causes inhibition of 
TESK1, making F-actin fibers dynamic (Johne et 
al., 2008). Taok1 controls epithelial morphogenesis 
by promoting Fas2 (Fasciclin 2, the insect 
homologue of NCAM1 (neural cell adhesion 
molecule 1, 11q23.2)) endocytosis in Drosophila 
melanogaster (Gomez et al., 2012). 




Fusion of PAX5 exon 5 to TAOK1 intron 19-20, 
but in reverse orientation. Transcript with exon 1B 




Predicted fusion protein of 218 amino acids. The 
predicted fusion protein contains the DNA binding 
paired domain of PAX5 (201 aa) and 17 amino 
acids. 
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